The ceruloplasmin and hydrogen peroxide system induces α-synuclein aggregation in vitro

Biochimie

Volumn 84, Issue 7, 2002, Pages 625-631

  Kim, Kyung Sik ^a   Choi, Soo Young ^b   Kwon, Hyeok Yil ^a   Won, Moo Ho ^b   Kang, Tae Cheon ^b   Kang, Jung Hoon ^a  

^a Chongju University   (South Korea)

^b Hallym University   (South Korea)

Author keywords

Synuclein; Ceruloplasmin; Lewy body; Parkinson's disease

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ALPHA SYNUCLEIN; ANSERINE; ANTIOXIDANT; AZIDE; CARBONYL DERIVATIVE; CARNOSINE; CERULOPLASMIN; CHELATING AGENT; COPPER ION; FORMIC ACID; FREE RADICAL; HOMOCARNOSINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; N TERT BUTYL ALPHA PHENYLNITRONE; PENICILLAMINE; SCAVENGER; THIOFLAVINE; NERVE PROTEIN; SNCA PROTEIN, HUMAN; SYNUCLEIN; THIAZOLE DERIVATIVE;

ARTICLE; BRAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HUMAN; IN VITRO STUDY; LEWY BODY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN MODIFICATION; SPIN TRAPPING; STATISTICAL SIGNIFICANCE; CHEMISTRY; ELECTRON MICROSCOPY; IMMUNOBLOTTING; METABOLISM; METHODOLOGY; PROTEIN FOLDING; SPECTROFLUOROMETRY; STAINING;

LETHRINIDAE;

ALPHA-SYNUCLEIN; CERULOPLASMIN; HUMANS; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOBLOTTING; MICROSCOPY, ELECTRON; NERVE TISSUE PROTEINS; PROTEIN FOLDING; SPECTROMETRY, FLUORESCENCE; STAINING AND LABELING; SYNUCLEINS; THIAZOLES;

EID: 0036661699     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(02)01435-9     Document Type: Article

References (51)

1. A. Takeda, M. Mallory, M. Sundsmo, W. Hoener, L. Hansen, E. Masliah, Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders, Am. J. Pathol. 152 (1998) 367-372.
2. M.G. Spillantini, M.L. Schmit, V.Y. Lee, J.Q. Trojannowski, R. Jakes, M. Goedert, Alpha-synuclein in Lewy bodies, Nature 388 (1977) 839-840.
3. K. Wakabayashi, K. Matsumoto, K. Takayama, M. Yoshimoto, H. Takahashi, NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease, Neurosci. Lett. 239 (1997) 45-48.
4. M.C. Irizarry, W. Growdon, T. Gomez-Isla, K. Newell, J.M. George, D.F. Clayton, B.T. Hyman, Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J. Neuropathol. Exp. Neurol. 57 (1998) 334-337.
5. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, T. Iwatsubo, Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies, Am. J. Pathol. 152 (1998) 879-884.
6. A. Takeda, M. Hashimoto, M. Mallory, M. Sundsmo, L. Hansen, A. Sisk, E. Masliah, Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment, Lab. Invest. 78 (1998) 1169-1177.
7. K. A. Conway, J.D. Harper, P.T. Lansbury Jr, Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid, Biochemistry 39 (2000) 2552-2563.
8. L.C. Serpell, J. Berriman, R. Jakes, M. Goedert, R.A. Crowther, Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation, Proc. Natl. Acad. Sci. USA 97 (2000) 4897-4902.
9. K.A. Conway, J.D. Harper, P.T. Lansbury, Accelerated in vitro fibril formation by mutant α-synuclein linked to early-onset Parkinson disease, Nat. Med. 4 (1998) 1318-1320.
10. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson, P.T. Lansbury Jr, Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy, Proc. Natl. Acad. Sci. USA 97 (2000) 571-576.
11. M. Goedert, M.G. Spillantini, S.W. Davies, Filamentous nerve cell inclusions in neurodegenerative diseases, Curr. Opin. Neurol. 8 (1998) 619-632.
12. M. Hashimoto, L.J. Hsu, Y. Xia, A. Takeda, A. Sisk, M. Sundsmo, E. Masliah, Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro, Neuroreport 10 (1999) 717-721.
13. S.R. Paik, H.J. Shin, J.H. Lee, Metal-catalyzed oxidation of α-synuclein in the presence of copper (II) and hydrogen peroxide, Arch. Biochem. Biophys. 378 (2000) 269-277.
14. B. Halliwell, J.M.C. Gutteridge, Oxygen toxicity, oxygen radicals, transition metals and disease, Biochem. J. 219 (1984) 1-14.
15. D. Steinberg, Role of oxidized LDL and antioxidants in atherosclerosis, Adv. Exp. Med. Biol. 369 (1995) 39-48.
16. J.H. Kang, S.M. Kim, Fragmentation of human Cu,Zn-superoxide dismutase by peroxidative reaction, Mol. Cells 7 (1997) 553-558.
17. M.B. Yim, J.H. Kang, H.S. Yim, H.S. Kawk, P.B. Chock, E.R. Stadtman, A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide, Proc. Natl. Acad. Sci. USA 93 (1996) 5709-5714.
18. W.S. Eum, J.H. Kang, Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutants, Mol. Cells 9 (1999) 110-114.
19. G. Multhaup, A. Schlicksupp, L. Hesse, D. Beher, T. Ruppert, C. Masters, K. Beyreuther, The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I), Science 271 (1996) 1406-1409.
20. N. Takahashi, T.L. Ortel, F.W. Putnam, Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule, Proc. Natl. Acad. Sci. USA 81 (1984) 390-394.
21. I. M. Goldstein, H. B. Kaplan, H.S. Edelson, G. Weissmann, Ceruloplasmin. A scavenger of superoxide anion radicals, J. Biol. Chem. 254 (1979) 4040-4045.
22. D.R. Winge, Normal physiology of copper metabolism, Semin. Liver Dis. 4 (1984) 239-251.
23. J. Folkman, M. Klagsburn, Angiogenic factors, Science 235 (1987) 442-447.
24. E.J. Walker, J. Fay, Characterization of an interaction between protein C and ceruloplasmin, J. Biol. Chem. 265 (1990) 1834-1836.
25. E. Ehrenwald, G.M. Chisolm, P.L. Fox, Intact human ceruloplasmin oxidatively modifies low density lipoprotein, J. Clin. Invest. 93 (1994) 1493-1501.
26. C.K. Mukhopadhyay, B. Mazumder, P.F. Lindley, P.L. Fox, Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces, Proc. Natl. Acad. Sci. USA 94 (1997) 11546-11551.
27. S.Y. Choi, H.Y. Kwon, O.B. Kwon, W.S. Eum, J.H. Kang, Fragmentation of human ceruloplasmin induced by hydrogen peroxide, Biochimie 82 (2000) 175-180.
28. R. Jakes, M.G. Spillantini, M. Goedert, Identification of two distinct synucleins from human brain, FEBS Lett. 345 (1994) 27-32.
29. R.L. Levine, J.A. Williams, E.R. Stadtman, E. Shacter, Carbonyl assays for determination of oxidatively modified proteins, Methods Enzymol. 233 (1994) 346-357.
30. R. Kohen, Y. Yamamoto, K.C. Cundy, B.N. Ames, Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc. Natl. Acad. Sci. USA 85 (1988) 3175-3179.
31. J.J. O'Dowd, D.J. Robins, D.J. Miller, Detection, characterisation, and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle, Biochim. Biophys. Acta 967 (1988) 241-249.
32. R.C. Harris, D.J. Marlin, M. Dunnett, D.H. Snow, E. Hultman, Muscle buffering capacity and dipeptide content in the thoroughbred horse, greyhound dog and man, Comp. Biochem. Physiol. A. 97 (1990) 249-251.
33. G.A. McFarland, R. Holliday, Retardation of the senescence of cultured human diploid fibroblasts by carnosine, Exp. Cell Res. 212 (1994) 167-175.
34. C.E. Brown, Interactions among carnosine, anserine, ophidine and copper in biochemical adaptation, J. Theorl. Biol. 88 (1981) 245-256.
35. W.K.M. Chan, E.A. Decker, J.B. Lee, D.A. Butterfield, EPR spin-trapping studies of the hydroxyl radical scavenging activity of carnosine and related dipeptides, J. Agric. Food. Chem. 42 (1994) 1407-1410.
36. B. Halliwell, Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol. Scand. 126 (1989) 23-33.
37. M.B. Youdim, D. Ben-Schachar, P. Riederer, Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol. Scand. 126 (1989) 47-54.
38. P. Jenner, C.W. Olanow, Oxidative stress and the pathogenesis of Parkinson's disease, Neurology 47 (1996) S161-70.
39. W.R. Markesbery, J.M. Carney, Oxidative alterations in Alzheimer's disease, Brain Pathol. 9 (1999) 133-146.
40. D.T. Dexter, A. Carayon, F. Javoy-Agid, Y. Agid, F.R. Wells, S.E. Daniel, A.J. Lees, P. Jenner, C.D. Marsden, Alterations in the levels of iron, ferritin, and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia, Brain 114 (1991) 1953-1975.
41. M. Gerlach, D. Ben Shachar, P. Riederer, B.H. Youdim, Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63 (1994) 793-807.
42. H.S. Pall, A.C. Williams, D.R. Blake, J. Lunec, J.M. Gutteridge, M. Hall, A. Taylor, Raised cerebrospinal-fluid copper concentration in Parkinson's disease, Lancet 2 (1987) 238-241.
43. G. Cohen, R. Farooqui, N. Kesler, Parkinson disease: a new link between monoamine oxidase and mitochondria electron flow, Proc. Natl. Acad. Sci. USA 94 (1997) 4890-4894.
44. D.A. Loeffler, P.A. LeWitt, P.L. Juneau, A.A. Sima, H.U. Nguyen, A.J. DeMaggio, C.M. Brickman, G.J. Brewer, R.D. Dick, M.D. Troyer, L. Kanaley, Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders, Brain Res. (1996) 265-274.
45. K.S. Kim, S.Y. Choi, H.Y. Kwon, M.H. Won, T.C. Kang, J.H. Kang, Aggregation of α-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system, Free Radic. Biol. Med. 32 (2002) 544-550.
46. R.E. Fleming, I.P. Whitman, J.D. Gitlin, Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia, Am. J. Physiol. 260 (1991) L68-L74.
47. G. Musci, M.C. Bonaccorsi di Patti, U. Fagiola, L. Calabrese, Age-related changes in human ceruloplasmin. Evidence for oxidative modifications, J. Biol. Chem. 268 (1993) 13388-13395.
48. O.F. Olesen, J.D. Mikkelsen, C. Gerdes, P.H. Jensen, Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid, Brain Res. Mol. Brain Res. 44 (1997) 105-112.
49. A.A. Boldyrev, A.M. Dupin, E.V. Pindel, S.E. Severin, Antioxidative properties of histidine-containing dipeptide from skeletal muscles of vertebrate, Comp. Biochem. Physiol. B 89 (1988) 245-250.
50. O.I. Aruoma, M.J. Laughton, B. Halliwell, Carnosine, homocarnosine and anserine: could they act as antioxidants in vivo? Biochem. J. 264 (1989) 863-869.
51. E.A. Decker, A.D. Crum, J.T. Cavert, Differences in the antioxidant mechanism of carnosine in the presence of copper and iron, J. Agric. Food Chem. 40 (1992) 756-759.